{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:16:47Z","timestamp":1775575007843,"version":"3.50.1"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA142509"],"award-info":[{"award-number":["CA142509"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA184464"],"award-info":[{"award-number":["CA184464"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01816","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T04:45:21Z","timestamp":1597293921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors"],"prefix":"10.3389","volume":"11","author":[{"given":"Richard J.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazal","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Jin","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhamed","family":"Baljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isere","family":"Kuiatse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Z.","family":"Orlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/jamaoncol.2019.1568","article-title":"Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma","volume":"5","author":"Landgren","year":"2019","journal-title":"JAMA Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/ejh.12894","article-title":"A first czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance","volume":"99","author":"Sandecka","year":"2017","journal-title":"Eur J Haematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12185-018-2555-7","article-title":"Characteristics and prognosis of patients with non-immunoglobulin-M monoclonal gammopathy of undetermined significance: a retrospective study","volume":"109","author":"Kuwabara","year":"2019","journal-title":"Int J Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/ejh.12728","article-title":"Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study","volume":"97","author":"Sorrig","year":"2016","journal-title":"Eur J Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41375-018-0013-4","article-title":"Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression","volume":"32","author":"Fernandez","year":"2018","journal-title":"Leukemia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1182\/bloodadvances.2018016998","article-title":"Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling","volume":"2","author":"Wu","year":"2018","journal-title":"Blood Adv."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0188988","DOI":"10.1371\/journal.pone.0188988","article-title":"Immunoparesis in newly diagnosed multiple myeloma patients: effects on overall survival and progression free survival in the Danish population","volume":"12","author":"Sorrig","year":"2017","journal-title":"PloS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41375-018-0163-4","article-title":"Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials","volume":"32","author":"Heaney","year":"2018","journal-title":"Leukemia."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1080\/10428194.2017.1403026","article-title":"Immunoparesis and polyclonal immunoglobulin recovery after auto-SCT for patients with multiple myeloma treated at a single institution","volume":"59","author":"Jimenez-Zepeda","year":"2018","journal-title":"Leukem Lymphom."},{"key":"B10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2016.158345","article-title":"Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma","volume":"102","author":"Gonzalez-Calle","year":"2017","journal-title":"Haematologica."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ejh.13066","article-title":"Risk factors for blood stream infections in multiple myeloma: a population-based study of 1154 patients in Denmark","volume":"101","author":"Sorrig","year":"2018","journal-title":"Eur J Haematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.7150\/jca.24288","article-title":"Multiple myeloma index for risk of infection","volume":"9","author":"Valkovic","year":"2018","journal-title":"J Cancer"},{"key":"B13","first-page":"1022","article-title":"Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules","volume":"88","author":"Cesana","year":"2003","journal-title":"Haematologica."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","article-title":"Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK group for immunoglobulin replacement therapy in multiple myeloma","volume":"343","author":"Chapel","year":"1994","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1365-2141.1995.tb08447.x","article-title":"Prophylaxis against infections with intravenous immunoglobulins in multiple myeloma","volume":"89","author":"Musto","year":"1995","journal-title":"Br J Haematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.blre.2019.01.001","article-title":"Management of infectious complications in multiple myeloma patients: expert panel consensus-based recommendations","volume":"34","author":"Girmenia","year":"2019","journal-title":"Blood Rev."},{"key":"B17","first-page":"76","article-title":"New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients","volume":"6","author":"Krivan","year":"2017","journal-title":"Am J Clin Exp Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti","year":"2017","journal-title":"Int Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00210-004-0877-x","article-title":"Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes\/macrophages","volume":"369","author":"Ichiyama","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00011-004-1255-3","article-title":"An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro","volume":"53","author":"Ichiyama","year":"2004","journal-title":"Inflamm Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00011-014-0744-2","article-title":"Intravenous immunoglobulin preparation prevents the production of pro-inflammatory cytokines by modulating NFkappaB and MAPKs pathways in the human monocytic THP-1 cells stimulated with procalcitonin","volume":"63","author":"Murakami","year":"2014","journal-title":"Inflamm Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainres.2018.06.009","article-title":"Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6\/2 mouse model of Huntington's disease by decreasing mutant huntingtin protein level and normalizing NF-kappaB signaling pathway","volume":"1697","author":"Liu","year":"2018","journal-title":"Brain Res."},{"key":"B23","first-page":"15879","article-title":"IVIG inhibits TNF-alpha-induced MMP9 expression and activity in monocytes by suppressing NF-kappaB and P38 MAPK activation","volume":"8","author":"Zhou","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.imlet.2017.02.015","article-title":"MiR-146a potentially promotes IVIg-mediated inhibition of TLR4 signaling in LPS-activated human monocytes","volume":"185","author":"Loubaki","year":"2017","journal-title":"Immunol Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00210-012-0765-8","article-title":"Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways","volume":"385","author":"Murakami","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-010-9469-3","article-title":"IVIg attenuates TLR-9 activation in B cells from SLE patients","volume":"31","author":"Kessel","year":"2011","journal-title":"J Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/B:JOCI.0000019809.55787.ec","article-title":"i","volume":"24","author":"Shoenfeld","year":"2004","journal-title":"J Clin Immunol."},{"key":"B28","first-page":"782","article-title":"Potential anti-tumor activity of intravenous and subcutaneous immunoglobulin","volume":"20","author":"Danieli","year":"2018","journal-title":"Isr Med Assoc J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1196\/annals.1423.032","article-title":"Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma","volume":"1110","author":"Schachter","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1182\/blood.V92.10.3721","article-title":"Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion","volume":"92","author":"Muller","year":"1998","journal-title":"Blood."},{"key":"B31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat Rev Clin Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biom6010015","article-title":"The Production Processes and Biological Effects of Intravenous Immunoglobulin","volume":"6","author":"Barahona Afonso","year":"2016","journal-title":"Biomolecules."},{"key":"B33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1385\/CRIAI:29:3:307","article-title":"Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy","volume":"29","author":"Sapir","year":"2005","journal-title":"Clin Rev Allergy Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1074\/jbc.M608667200","article-title":"Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme, DHRS9","volume":"282","author":"Jones","year":"2007","journal-title":"J Bio Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Hong","year":"2005","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2105-9-85","article-title":"Statistical issues in the analysis of illumina data","volume":"9","author":"Dunning","year":"2008","journal-title":"BMC Bioinform."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1182\/blood-2011-10-386789","article-title":"Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma","volume":"120","author":"Kuhn","year":"2012","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1038\/ncomms8029","article-title":"Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters","volume":"6","author":"Lai","year":"2015","journal-title":"Nat Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/pst.369","article-title":"Interval approach to assessing antitumor activity for tumor xenograft studies","volume":"9","author":"Wu","year":"2010","journal-title":"Pharm Stat."},{"key":"B40","first-page":"1","article-title":"A. Pharmacokinetics of intravenous immunoglobulin preparations","volume-title":"Intravenous Immunoglobulins in Clinical Practice","author":"Lee","year":"1997"},{"key":"B41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1083\/jcb.200907074","article-title":"Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response","volume":"187","author":"Schuck","year":"2009","journal-title":"J Cell Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.1073\/pnas.1603883113","article-title":"Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma","volume":"113","author":"Sabnis","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"15571","DOI":"10.1074\/jbc.C100055200","article-title":"Stable association of hsp90 and p23, but Not hsp70, with active human telomerase","volume":"276","author":"Forsythe","year":"2001","journal-title":"J Biol Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"eaav4409","DOI":"10.1126\/sciadv.aav4409","article-title":"Telomerase promotes formation of a telomere protective complex in cancer cells","volume":"5","author":"Perera","year":"2019","journal-title":"Sci Adv."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1038\/onc.2009.281","article-title":"Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions","volume":"28","author":"Walerych","year":"2009","journal-title":"Oncogene."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.febslet.2005.02.046","article-title":"Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial\/epithelial cells","volume":"579","author":"Theriault","year":"2005","journal-title":"FEBS Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/978-1-4939-7477-1_29","article-title":"Clinical evaluation and biomarker profiling of hsp90 inhibitors","volume":"1709","author":"Yuno","year":"2018","journal-title":"Methods Mol Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"14374","DOI":"10.1073\/pnas.202445099","article-title":"Molecular sequelae of proteasome inhibition in human multiple myeloma cells","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12192-010-0247-1","article-title":"Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies","volume":"16","author":"Multhoff","year":"2011","journal-title":"Cell Stress Chaperones."},{"key":"B50","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","article-title":"Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes","volume":"113","author":"Kowal","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1128\/MCB.7.12.4357","article-title":"Posttranscriptional regulation of hsp70 expression in human cells: effects of heat shock, inhibition of protein synthesis, and adenovirus infection on translation and mRNA stability","volume":"7","author":"Theodorakis","year":"1987","journal-title":"Mol Cell Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1432-1033.1995.tb20719.x","article-title":"Transient acquired thermotolerance in drosophila, correlated with rapid degradation of Hsp70 during recovery","volume":"231","author":"Li","year":"1995","journal-title":"Eur J Biochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BJ20082309","article-title":"Hsp70 is required for optimal cell proliferation in mouse A6 mesoangioblast stem cells","volume":"421","author":"Turturici","year":"2009","journal-title":"Biochem J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1159\/000480213","article-title":"Extracellular HSP70 Activates ERK1\/2, NF-kB and pro-inflammatory gene transcription through binding with RAGE in A549 human lung cancer cells","volume":"42","author":"Somensi","year":"2017","journal-title":"Cell Physiol Biochem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1046\/j.1432-1327.2000.01112.x","article-title":"Activation and regulation of Hsp32 and Hsp70","volume":"267","author":"Stuhlmeier","year":"2000","journal-title":"Eur J Biochem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/carcin\/bgt111","article-title":"The HSP70 family and cancer","volume":"34","author":"Murphy","year":"2013","journal-title":"Carcinogenesis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1073\/pnas.1016065108","article-title":"Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70","volume":"108","author":"Stangl","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"20160526","DOI":"10.1098\/rstb.2016.0526","article-title":"Membrane heat shock protein 70: a theranostic target for cancer therapy","volume":"373","author":"Shevtsov","year":"2018","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1379\/1466-1268(1998)003<0006:DOELEO>2.3.CO;2","article-title":"Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response","volume":"3","author":"Botzler","year":"1998","journal-title":"Cell Stress Chaperones."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0301-472X(99)00104-6","article-title":"Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells","volume":"27","author":"Multhoff","year":"1999","journal-title":"Exp Hematol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/intimm\/11.8.1247","article-title":"Gamma-globulin inhibits tumor spread in mice","volume":"11","author":"Shoenfeld","year":"1999","journal-title":"Int Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/cncr.10905","article-title":"Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages","volume":"95","author":"Shapiro","year":"2002","journal-title":"Cancer."},{"key":"B63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2249.2009.04026.x","article-title":"Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation","volume":"158","author":"Schwartz-Albiez","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B64","first-page":"698","article-title":"Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment","volume":"3","author":"Shoenfeld","year":"2001","journal-title":"Isr Med Assoc J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fimmu.2014.00674","article-title":"Immunomodulation by Ivig and the role of fc-gamma receptors: classic mechanisms of action after all?","volume":"5","author":"Nagelkerke","year":"2014","journal-title":"Front Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12192-008-0067-8","article-title":"Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia","volume":"14","author":"Molvarec","year":"2009","journal-title":"Cell Stress Chaperones."},{"key":"B67","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12192-016-0758-5","article-title":"The expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in peripheral blood of patients with HCC and lung cancer","volume":"22","author":"Ren","year":"2017","journal-title":"Cell Stress Chaperones."},{"key":"B68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12192-009-0146-5","article-title":"Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies","volume":"15","author":"Molvarec","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"B69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1379\/CSC-130R1.1","article-title":"Birth defects and anti-heat shock protein 70 antibodies in early pregnancy","volume":"11","author":"Child","year":"2006","journal-title":"Cell Stress Chaperones."},{"key":"B70","doi-asserted-by":"publisher","first-page":"394632017750440","DOI":"10.1177\/0394632017750440","article-title":"Elevated circulating heat shock protein 70 and its antibody concentrations in chronic spontaneous urticaria","volume":"31","author":"Kasperska-Zajac","year":"2018","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e110443","DOI":"10.1371\/journal.pone.0110443","article-title":"Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins","volume":"9","author":"Ghosh","year":"2014","journal-title":"PLoS ONE."},{"key":"B72","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/jnci\/djv330","article-title":"Restoring anticancer immune response by targeting tumor-derived exosomes with a hsp70 peptide aptamer","volume":"108","author":"Gobbo","year":"2016","journal-title":"J Natl Cancer Inst."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/sctm.16-0297","article-title":"First characterization of human amniotic fluid stem cell extracellular vesicles as a powerful paracrine tool endowed with regenerative potential","volume":"6","author":"Balbi","year":"2017","journal-title":"Stem Cell Transl Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-017-2690-y","article-title":"Post-translational add-ons mark the path in exosomal protein sorting","volume":"75","author":"Moreno-Gonzalo","year":"2018","journal-title":"Cell Mol Life Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-18-2363","article-title":"Exosome-Transmitted PSMA3 and PSMA3-AS1 promote proteasome inhibitor resistance in multiple myeloma","volume":"25","author":"Xu","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ymeth.2007.06.006","article-title":"Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance","volume":"43","author":"Multhoff","year":"2007","journal-title":"Methods."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T04:45:27Z","timestamp":1597293927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2020.01816"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01816","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"article-number":"1816"}}